First Wave BioPharma Inc. [NASDAQ: FWBI] traded at a high on 01/04/23, posting a 24.29 gain after which it closed the day’ session at $1.10. The company report on December 12, 2022 that First Wave BioPharma to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2023”.
The results of the trading session contributed to over 4129824 shares changing hands. Over the past one week, the price volatility of First Wave BioPharma Inc. stands at 50.40% while the volatility over the past one month is 24.94%.
The market cap for FWBI stock reached $5.78 million, with 5.80 million shares outstanding and 5.80 million shares in the current float. Compared to the average trading volume of 874.48K shares, FWBI reached a trading volume of 4129824 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about First Wave BioPharma Inc. [FWBI]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FWBI shares is $11.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FWBI stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has FWBI stock performed recently?
First Wave BioPharma Inc. [FWBI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 120.88. With this latest performance, FWBI shares gained by 30.91% in over the last four-week period, additionally sinking by -85.27% over the last 6 months – not to mention a drop of -97.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FWBI stock in for the last two-week period is set at 70.98, with the RSI for the last a single of trading hit 81.46, and the three-weeks RSI is set at 60.30 for First Wave BioPharma Inc. [FWBI]. The present Moving Average for the last 50 days of trading for this stock 0.8094, while it was recorded at 0.8281 for the last single week of trading, and 7.4477 for the last 200 days.
First Wave BioPharma Inc. [FWBI]: Deeper insight into the fundamentals
First Wave BioPharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.40 and a Current Ratio set at 0.40.
Insider trade positions for First Wave BioPharma Inc. [FWBI]
There are presently around $0 million, or 2.00% of FWBI stock, in the hands of institutional investors. The top three institutional holders of FWBI stocks are: STATE STREET CORP with ownership of 82,593, which is approximately 5824.892% of the company’s market cap and around 0.14% of the total institutional ownership; VIRTU FINANCIAL LLC, holding 12,628 shares of the stock with an approximate value of $14000.0 in FWBI stocks shares; and JANE STREET GROUP, LLC, currently with $11000.0 in FWBI stock with ownership of nearly 590.252% of the company’s market capitalization.
Positions in First Wave BioPharma Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 9 institutional holders increased their position in First Wave BioPharma Inc. [NASDAQ:FWBI] by around 107,669 shares. Additionally, 10 investors decreased positions by around 11,108 shares, while 4 investors held positions by with 4,073 shares. The mentioned changes placed institutional holdings at 114,704 shares, according to the latest SEC report filing. FWBI stock had 4 new institutional investments in for a total of 2,434 shares, while 9 institutional investors sold positions of 10,969 shares during the same period.